← Back to Search

Genetic Education for Prostate Cancer

N/A
Recruiting
Led By Ewan K Cobran, PhD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Localized prostate cancer (stage 1 and 2)
Age 40 and older
Must not have
Men with metastatic prostate cancer
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediately after the intervention
Awards & highlights

Summary

This trial is investigating how well patients and their caregivers understand and communicate prognostic genetic technology surrounding localized prostate cancer.

Who is the study for?
This study is for English-speaking African American and rural White men aged 40 or older who have early-stage (stage 1 or 2) prostate cancer. Participants must be willing to provide informed consent and participate in the study. Men with advanced prostate cancer, plans to move soon, or severe mental illness like dementia cannot join.
What is being tested?
The trial is focused on understanding how these men perceive genetic technology that helps predict the outcome of localized prostate cancer. It involves participating in focus group discussions to gather insights into their decision-making processes regarding treatment planning.
What are the potential side effects?
Since this trial involves focus group discussions rather than medical treatments, there are no direct physical side effects associated with participation. However, discussing personal health issues can sometimes lead to emotional or psychological discomfort.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My prostate cancer is in the early stages (1 or 2).
Select...
I am 40 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am a man with prostate cancer that has spread.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediately after the intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and immediately after the intervention for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Estimate Genetic Literacy
Focus Group Discussion
Prostate Cancer Genetic Understanding
Secondary study objectives
Demographic Characteristics
Prostate

Trial Design

2Treatment groups
Experimental Treatment
Group I: Prostate Cancer Genetic Literacy Application (PCGLA) Educational Video.Experimental Treatment1 Intervention
Focus group discussions about the PCGLA educational video post-study. Focus group audiotapes will be transcribed verbatim, and then entered into the qualitative data software package, NVivo 14. A data dictionary will be created for each technical term to establish acceptable and unacceptable responses. Trained coders will evaluate comprehension of the technical terms independently and then resolve disagreement by consensus.
Group II: Prostate Cancer Genetic Literacy Application (PCGLA) Educational Video plus Communication Coaching.Experimental Treatment1 Intervention
Focus group discussions about the PCGLA educational plus nurse-navigated, tailored, prostate cancer education and communication coaching post-study. Focus group audiotapes will be transcribed verbatim, and then entered into the qualitative data software package, NVivo 14. A data dictionary will be created for each technical term to establish acceptable and unacceptable responses. Trained coders will evaluate comprehension of the technical terms independently and then resolve disagreement by consensus. post-study. Focus group audiotapes will be transcribed verbatim, and then entered into the qualitative data software package, NVivo 14. A data dictionary will be created for each technical term to establish acceptable and unacceptable responses. Trained coders will evaluate comprehension of the technical terms independently and then resolve disagreement by consensus.

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,298 Previous Clinical Trials
3,958,355 Total Patients Enrolled
36 Trials studying Prostate Cancer
8,488 Patients Enrolled for Prostate Cancer
National Cancer Institute (NCI)NIH
13,842 Previous Clinical Trials
41,002,910 Total Patients Enrolled
566 Trials studying Prostate Cancer
529,719 Patients Enrolled for Prostate Cancer
University of GeorgiaLead Sponsor
102 Previous Clinical Trials
44,658 Total Patients Enrolled

Media Library

Prostate Cancer Genetic Literacy Application (PCGLA) Educational Video. Clinical Trial Eligibility Overview. Trial Name: NCT04550845 — N/A
Prostate Cancer Research Study Groups: Prostate Cancer Genetic Literacy Application (PCGLA) Educational Video., Prostate Cancer Genetic Literacy Application (PCGLA) Educational Video plus Communication Coaching.
Prostate Cancer Clinical Trial 2023: Prostate Cancer Genetic Literacy Application (PCGLA) Educational Video. Highlights & Side Effects. Trial Name: NCT04550845 — N/A
Prostate Cancer Genetic Literacy Application (PCGLA) Educational Video. 2023 Treatment Timeline for Medical Study. Trial Name: NCT04550845 — N/A
~60 spots leftby Sep 2027
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top